Contravir hepion
WebThe company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2024. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey. income statement balance sheet cash flow annual quarterly values in Millions, USD WebJul 22, 2024 · Data & APIs. Events. Marketfy
Contravir hepion
Did you know?
WebAug 27, 2024 · contravir. Press Release. Hepion Pharmaceuticals Highlights Upcoming Phase 2 Clinical Trials of Rencofilstat at 5th Global NASH Congress. EDISON, N.J., May … WebEDISON, N.J., Feb. 09, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial …
WebHepion Pharmaceuticals. Business Services · New Jersey, United States · <25 Employees . ContraVir is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV). WebHepion Pharmaceuticals (Nasdaq: HEPA) is a biopharmaceutical company focused on the development of pleiotropic drug therapy for treatment of chronic liver disease.
WebApr 6, 2024 · According to the current price, ContraVir Pharmaceuticals is 60.32% away from the 52-week high. What are analysts forecasts for ContraVir Pharmaceuticals … WebHepion Pharmaceuticals eps - earnings per share from 2014 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants. Compare HEPA With Other Stocks From: To: Zoom:
WebHepion Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and...
WebJul 22, 2024 · ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to HEPA. Posted on 07/22/2024 287 sv nikola slava datumWebHepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), fibrotic diseases, hepatocellular carcinoma (“HCC”), and other chronic diseases. sv nikolska crkva u nisuWebPhone Number +1 732 902-4000. Hepion Pharmaceuticals provides the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and … sv nikola slava datum 2021WebNov 21, 2024 · Shares of Hepion Pharmaceuticals Inc (NASDAQ: HEPA), formerly ContraVir Pharma, are ripping higher after the thinly-traded, nano-cap biotech … sv nikola tavelićWebSenior Director, Clinical Development at Hepion Pharmaceuticals, Inc. Penns Park, Pennsylvania, United States 366 followers 358 connections … baseball cap luggageWebJul 22, 2024 · Hepion Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and ... baseball cap luxuryWebPreviously Dr. Matkovits served as the Chief Operating Officer of ContraVir Pharmaceuticals (now Hepion) (NASDAQ: CTRV) where she was instrumental in the establishment and build-out of its global development organization with responsibility and oversight for Clinical Development, Regulatory, Manufacturing, Quality, and Project … baseball cap line drawing